US · 21 CFR
21 CFR 601.50
Confidentiality of data and information in an investigational new drug notice for a biological product.
21 CFR Part 601 › Subpart F—Confidentiality of Information
조항 원문
(a) The existence of an IND notice for a biological product will not be disclosed by the Food and Drug Administration unless it has previously been publicly disclosed or acknowledged.
(b) The availability for public disclosure of all data and information in an IND file for a biological product shall be handled in accordance with the provisions established in § 601.51.
(c) Notwithstanding the provisions of § 601.51, the Food and Drug Administration shall disclose upon request to an individual on whom an investigational biological product has been used a copy of any adverse reaction report relating to such use.
본문은 원문(영어)입니다. 국문 번역은 준비 중입니다.
각주·출처 표기
- [39 FR 44656, Dec. 24, 1974]
출처: U.S. Office of the Federal Register / GPO — eCFR · U.S. federal government work — public domain (17 U.S.C. §105). eCFR is an editorial compilation, not an official legal edition of the CFR. · 수집일 2026-11-16